OVUM highlights the potential of AI in revolutionizing IVF

FHS
July 1, 2023
3:43 pm

The reproductive and fertility wellness brand, OVUM, highlights the potential of artificial intelligence (AI) in revolutionizing the In vitro fertilization (IVF) field.

Impact of TLR10 rs10004195 genotype on susceptibility to H. pylori infection

Helicobacter pylori (H. pylori) infection can cause multiple secondary digestive disorders. Some studies have found that polymorphisms in Toll-like receptor (TLR) genes, including TLR10 rs10004195,

October 27, 2024

Doudna institute hatches plan to ‘cure hundreds of diseases’ left behind by CRISPR revolution

Researchers attending gene therapy meetings over the past couple years were liable to bump into a svelte, graying scientist explaining in emphatic, Russian-inflected English that

January 9, 2024

Vyne aims to raise $88M; Sanofi invests in gene therapy company; 4DMT addresses clinical hold

Plus, news about United Therapeutics and Moderna: Immuno-inflammation biotech’s $88M: Vyne Therapeutics announced an $88 million private placement to, in part, help fund a Phase

October 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.